3-Hour Virtual Training: Russia Regulatory Compliance Requirements for Life Science Products
Structured healthcare systems and insurance coverage is now more prevalent among emerging nations and predictions for growth of Rx and OTC products is impressive in this relatively untapped market.
Rising health concerns, improved healthcare infrastructure, and rising adoption of new technology are some of the key factors driving growth. Medical devices, medicines, health wearables may grow in interest in emerging markets and contribute to preventive care to help to reduce long term healthcare costs.
Improved alignment to global standards is an important step forward toward foreign access, because it eliminates conflicting standards that prevailed among provincial government agencies. Healthcare authorities and regulatory systems have now made their requirements and procedures more transparent to industry partners. Clinical trials can be conducted at a fraction of the expense. As noted in the recent publication A Silver Lining: The Investment Implications of an Aging World urges institutional investors to consider how a graying world could impact their portfolios.
Comments
Post a Comment